120 likes | 231 Views
Fate of Un-replaced Sinuses of Valsalva in Bicuspid Aortic Valve Disease: Follow-up to 17 years. Chan Park 1 , Hector Michelena 2 , Thoralf M. Sundt 1 Divisions of Cardiovascular Surgery 1 and Cardiovascular Medicine 2 Mayo Clinic Rochester, Minnesota. Patient Characteristics.
E N D
Fate of Un-replaced Sinuses of Valsalva in Bicuspid Aortic Valve Disease: Follow-up to 17 years Chan Park1, Hector Michelena2, Thoralf M. Sundt1 Divisions of Cardiovascular Surgery1 and Cardiovascular Medicine2 Mayo Clinic Rochester, Minnesota
Outcomes • Operative mortality: 2.8% • Overall mortality: 28/218 (12.8%) • Cause of death Cardiac 5/28 (17.9%) Non-cardiac 11/28 (39.3%) Unknown 12/28 (42.9%)
Reoperation • Reoperation: 10/218 (4.6%) • Indication Aortic root dilation (1) Ascending aorta dilatation (2) PVE (3) PPM (2) Others (4)
Survival Freedom from Reoperation 100 80 60 Probability (%) 40 1 year probability: 97.6% 5 year probabilitiy: 94.9% 10 year probability: 85.5% 20 0 0 2 4 6 8 10 Follow-up (years)
Size (mm) Annulus Sinus STJ AscAo Change of Aortic Size at 5 years (n= 28) * † * * p<0.05 preop vs postop, †p<0.001 preop vs postop
Conclusions • The sinuses of Valsalva rarely dilate significantly after AVR and aortic repair • Separate valve and graft remains a reasonable option in the absence of significant root dilatation • The ascending aorta remains at risk of late dilatation if treated with aortoplasty